Which Drug Best Reduces Sleepiness in Patients With OSA?
A systematic review indicates that solriamfetol (Sunosi) is likely superior to other wake-promoting agents in reducing excessive daytime sleepiness in patients with obstructive sleep apnea.
Stay updated with breaking news from Sogol Javaheri. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A systematic review indicates that solriamfetol (Sunosi) is likely superior to other wake-promoting agents in reducing excessive daytime sleepiness in patients with obstructive sleep apnea.
Keeping your partner — or yourself — up at night with loud snoring? This might be more than a nuisance. About 25% of men and nearly 10% of women have obstructive sleep apnea (OSA), a serious sleep disorder characterized by explosive snores, grunts, and gasps. Tissue at the back of the throat temporarily obstructs the airway, leading to breathing pauses (apneas) throughout the night. Not only does OSA leave people tired and groggy, but it also puts them at risk for a host of health problems, including high blood pressure, depression, and heart disease. The most effective and best-studied t...